MHRA (Medicines and Healthcare products Regulatory Agency) study day on safe device use:
This article was originally published in Clinica
Executive Summary
In a bid to promote the "crucial role of practice nurses in ensuring safe medical device use", the UK's Medicines and Healthcare products Regulatory Agency (MHRA) is hosting a Study Day for Practice Nurses, on September 27, in London. Topics include: the Device Evaluation Programme; point-of-care testing in primary care; adverse incident reporting; decontamination; devices in the home setting; and vaccination/immunisation. The event will be a one-off, the MHRA told Clinica. For information and registration, go to: www.mhra.gov.uk/conferences/register
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.